DR. JAMES ANTAKI JOINS MI-VAD TECHNICAL ADVISORY BOARD AS CHAIRMAN.
MI-VAD, Inc. is pleased to announce the appointment of James F. Antaki, PhD, of Ithaca New York as Chairman of our Technical Advisory Board.
“I am straining at my leash to apply lessons learned over the past three decades (!) towards this truly superior, disruptive heart-assist solution. I’m exceptionally grateful for the opportunity to contribute to this worthy endeavor – that will improve the quality of patients lives who are suffering from advanced heart failure”
Dr. Antaki currently serves as the Lowell and Susan McAdam Professor of Heart Assist Technology, Department of Biomedical Engineering at Cornell University in Ithaca, New York. Most recently, he served as Professor, Biomedical Engineering & Computer Science at Carnegie Mellon University in Pittsburgh.
He is a recognized specialist in the field of ventricular assist devices and associated fluid flow technology, He has been involved in artificial heart research since the first implantation of the Jarvik-7 in Pittsburgh in 1985. He is a widely published author, and an award winning engineer specializing in design and deployment of blood-wetted medical devices. He is recognized by his peers as a pioneer in bio-medically engineered cardiac assist devices. Over the past 25 years he has contributed to development of number of cardiac assist devices used clinically including Heartmate-II, Novacor, Ventracor, TandemHeart and Levacor.
Dr. Antaki was intimately involved and was integral to the success of MI-VAD’s Phase 1 development program that resulted in the successful preliminary animal studies and proof of concept. Dr. Antaki will continue to working closely with MI-VAD on the hydrodynamic capabilities of its device.
MI-VAD, Inc. is a privately owned developmental stage medical device company that is continuing its development of a novel and potentially revolutionary minimally invasive mechanical blood circulatory pump, or ventricular assist device (VAD) that can change the management of end-stage heart failure. For more information, contact us at info@mivadinc.com